Data updated: May 30, 2026
DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE) (adapalene, benzoyl peroxide)
Approved 2026-05-22
1
Indication
--
Phase 3 Trials
0
Years on Market
Details
- Status
- Prescription
- First Approved
- 2026-05-22
- Routes
- N/A
- Dosage Forms
- GEL
DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE) Approval History
Original
New Indication
New Form
Label Update
4 FDA actions from 2026 to 2026
What DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE) Treats
1 FDA approvalsOriginally approved for its first indication in 2026 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE) FDA Label Details
Track DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE) with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.